248 related articles for article (PubMed ID: 29300102)
1. Curcumin and Melanoma: From Chemistry to Medicine.
Nabavi SM; Russo GL; Tedesco I; Daglia M; Orhan IE; Nabavi SF; Bishayee A; Nagulapalli Venkata KC; Abdollahi M; Hajheydari Z
Nutr Cancer; 2018; 70(2):164-175. PubMed ID: 29300102
[TBL] [Abstract][Full Text] [Related]
2. Prospective of curcumin, a pleiotropic signalling molecule from Curcuma longa in the treatment of Glioblastoma.
Luthra PM; Lal N
Eur J Med Chem; 2016 Feb; 109():23-35. PubMed ID: 26748069
[TBL] [Abstract][Full Text] [Related]
3. The clinical applications of curcumin: current state and the future.
Fan X; Zhang C; Liu DB; Yan J; Liang HP
Curr Pharm Des; 2013; 19(11):2011-31. PubMed ID: 23116310
[TBL] [Abstract][Full Text] [Related]
4. Curcumin nanomedicine: a road to cancer therapeutics.
Yallapu MM; Jaggi M; Chauhan SC
Curr Pharm Des; 2013; 19(11):1994-2010. PubMed ID: 23116309
[TBL] [Abstract][Full Text] [Related]
5. Curcumin and its formulations: potential anti-cancer agents.
Ji JL; Huang XF; Zhu HL
Anticancer Agents Med Chem; 2012 Mar; 12(3):210-8. PubMed ID: 22044005
[TBL] [Abstract][Full Text] [Related]
6. Curcumin and treatment of melanoma: The potential role of microRNAs.
Lelli D; Pedone C; Sahebkar A
Biomed Pharmacother; 2017 Apr; 88():832-834. PubMed ID: 28167449
[TBL] [Abstract][Full Text] [Related]
7. Perspectives on new synthetic curcumin analogs and their potential anticancer properties.
Vyas A; Dandawate P; Padhye S; Ahmad A; Sarkar F
Curr Pharm Des; 2013; 19(11):2047-69. PubMed ID: 23116312
[TBL] [Abstract][Full Text] [Related]
8. A review of therapeutic effects of curcumin.
Noorafshan A; Ashkani-Esfahani S
Curr Pharm Des; 2013; 19(11):2032-46. PubMed ID: 23116311
[TBL] [Abstract][Full Text] [Related]
9. Curcumin and Cancer.
Giordano A; Tommonaro G
Nutrients; 2019 Oct; 11(10):. PubMed ID: 31590362
[TBL] [Abstract][Full Text] [Related]
10. Promising curcumin-based drug design: mono-carbonyl analogues of curcumin (MACs).
Zhao C; Liu Z; Liang G
Curr Pharm Des; 2013; 19(11):2114-35. PubMed ID: 23116317
[TBL] [Abstract][Full Text] [Related]
11. The use of curcumin as an effective adjuvant to cancer therapy: A short review.
Bashang H; Tamma S
Biotechnol Appl Biochem; 2020 Mar; 67(2):171-179. PubMed ID: 31608504
[TBL] [Abstract][Full Text] [Related]
12. Delivery of curcumin and medicinal effects of the copper(II)-curcumin complexes.
Leung MH; Harada T; Kee TW
Curr Pharm Des; 2013; 19(11):2070-83. PubMed ID: 23116313
[TBL] [Abstract][Full Text] [Related]
13. Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment.
Naksuriya O; Okonogi S; Schiffelers RM; Hennink WE
Biomaterials; 2014 Mar; 35(10):3365-83. PubMed ID: 24439402
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the Anti-cancer Efficacy of a Synthetic Curcumin Analog on Human Melanoma Cells and Its Interaction with Standard Chemotherapeutics.
Parashar K; Sood S; Mehaidli A; Curran C; Vegh C; Nguyen C; Pignanelli C; Wu J; Liang G; Wang Y; Pandey S
Molecules; 2019 Jul; 24(13):. PubMed ID: 31284561
[TBL] [Abstract][Full Text] [Related]
15. Curcumin induces autophagy, inhibits proliferation and invasion by downregulating AKT/mTOR signaling pathway in human melanoma cells.
Zhao G; Han X; Zheng S; Li Z; Sha Y; Ni J; Sun Z; Qiao S; Song Z
Oncol Rep; 2016 Feb; 35(2):1065-74. PubMed ID: 26573768
[TBL] [Abstract][Full Text] [Related]
16. Mechanistic Understanding of Curcumin's Therapeutic Effects in Lung Cancer.
Wan Mohd Tajuddin WNB; Lajis NH; Abas F; Othman I; Naidu R
Nutrients; 2019 Dec; 11(12):. PubMed ID: 31817718
[TBL] [Abstract][Full Text] [Related]
17. Lesson learned from nature for the development of novel anti-cancer agents: implication of isoflavone, curcumin, and their synthetic analogs.
Sarkar FH; Li Y; Wang Z; Padhye S
Curr Pharm Des; 2010 Jun; 16(16):1801-12. PubMed ID: 20345353
[TBL] [Abstract][Full Text] [Related]
18. Combined therapy using bevacizumab and turmeric ethanolic extract (with absorbable curcumin) exhibited beneficial efficacy in colon cancer mice.
Yue GG; Kwok HF; Lee JK; Jiang L; Wong EC; Gao S; Wong HL; Li L; Chan KM; Leung PC; Fung KP; Zuo Z; Lau CB
Pharmacol Res; 2016 Sep; 111():43-57. PubMed ID: 27241019
[TBL] [Abstract][Full Text] [Related]
19. Curcumin and Its Derivatives as Potential Therapeutic Agents in Prostate, Colon and Breast Cancers.
Mbese Z; Khwaza V; Aderibigbe BA
Molecules; 2019 Nov; 24(23):. PubMed ID: 31801262
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel compound (β-sesquiphellandrene) from turmeric (Curcuma longa) with anticancer potential: comparison with curcumin.
Tyagi AK; Prasad S; Yuan W; Li S; Aggarwal BB
Invest New Drugs; 2015 Dec; 33(6):1175-86. PubMed ID: 26521943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
